ACELYRIN Revenue and Competitors
Estimated Revenue & Valuation
- ACELYRIN's estimated annual revenue is currently $27.5M per year.
- ACELYRIN's estimated revenue per employee is $193,750
- ACELYRIN's total funding is $550M.
Employee Data
- ACELYRIN has 142 Employees.
- ACELYRIN grew their employee count by 95% last year.
ACELYRIN's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Chief Technical Operations Officer | Reveal Email/Phone |
3 | Chief Technical Officer | Reveal Email/Phone |
4 | Chief Commercial Officer | Reveal Email/Phone |
5 | Head eClinical Programming & Solutions | Reveal Email/Phone |
6 | Head Global Supply Chain, External Manufacturing, and Program Management | Reveal Email/Phone |
7 | VP CMC Biologics | Reveal Email/Phone |
8 | VP, Quality | Reveal Email/Phone |
9 | SVP, Investor Relations and Corporate Communications | Reveal Email/Phone |
10 | VP Alliance Management, Clinical and Corporate Quality | Reveal Email/Phone |
ACELYRIN Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is ACELYRIN?
ACELYRIN, INC. is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. ACELYRIN is embedding a corporate culture of Courageous Caring™—placing patients first and embracing the concept that all of us are better than any one of us. ACELYRIN addresses the most basic human needs—to live a productive life free from diseases.
keywords:N/A
$550M
Total Funding
142
Number of Employees
$27.5M
Revenue (est)
95%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ACELYRIN News
ACELYRIN, INC., is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and...
Affibody enters agreement with ACELYRIN for the development and commercialization of izokibep at a total deal value of USD 305 million plus royalties Tue, Nov 16, 2021 15:20 CET Solna, Sweden, November 16, 2021. Affibody AB today announced a partnership agreement with ACELYRIN, INC., (“ACELYRIN ...
LOS ANGELES, Nov. 16, 2021 /PRNewswire/ -- ACELYRIN, INC., an innovative clinical-stage biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies, today announced the completion of a $250 million Series B financing led by AyurMa ...
Affibody enters agreement with ACELYRIN for the development and commercialization of izokibep at a total deal value of USD 305 million plus royalties Tue, Nov 16, 2021 15:20 CET Solna, Sweden, November 16, 2021. Affibody AB today announced a partnership agreement with ACELYRIN, INC., (“ACELYRIN ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $22.1M | 142 | -21% | $66M |
#2 | $20.3M | 142 | -1% | N/A |
#3 | $51.5M | 142 | 7% | N/A |
#4 | $45.3M | 142 | 4% | N/A |
#5 | $23.4M | 142 | 10% | N/A |